11 June 2015, Conference, Wellcome Trust, London, UK
11 June 2015
Wellcome Trust, London, UK
This one-day regulatory conference will showcase the collaborative approach between stakeholders to support innovation and to facilitate clinical development and timely access to new treatments and vaccines.
Experts and speakers from the MHRA and the National Institute for Biological Standards and Control (NIBSC), the life science industry, the Wellcome Trust, the Jenner Institute and patient organisations will highlight the latest thinking on topics including: patient involvement in regulatory decision-making and drug development; NIBSC MHRA post-merger: this session is focusing on advanced therapy medicinal products and biosimilars; accelerated regulatory approvals and processes – case study: Response against the Ebola Virus Disease from bench science to clinical research, lessons learned and applicability to other therapeutic areas.
Organisers: UK Bioindustry Association (BIA) and the Medicines and Healthcare products Regulatory Agency (MHRA)